NIPERs should establish National level testing labs for pharma products for revenue generation: Minister

The Minister suggested also that all NIPERs should try to establish the National level testing labs for the pharma products as a source of revenue generations

Published On 2020-06-12 11:29 GMT   |   Update On 2020-06-12 11:55 GMT

Delhi: A meeting of the Directors of National Institute of Pharmaceuticals Education and Research (NIPERs) –Mohali, Raebareill, Hajipur, and Guwahati through video conferencing was held under the chairmanship of Shri Mansukh Mandaviya , Mos Chemicals and Fertilizers here to review their performance in research & innovation activities especially with regard to the ways in which NIPERs have and can contribute in country's fight against COVID-19 pandemic.

Speaking on the occasion, Shri Mandaviya stressed that the NIPERs can be self-sustainable by generating their own resources through research and testing activities.

He also emphasised that NIPERs should focus not only on product development but also the scope of their commercialisation should also be explored.

The Minister suggested also that all NIPERs should try to establish the National level testing labs for the pharma products as a source of revenue generations. Government and Private Sector Pharmaceutical Companies and Agencies can approach NIPERs for use of the Testing Lab on a commercial basis.

Shri Mandaviya made his observations on issues raised by various NIPERs.

NIPERs, the first presentation was done by Director, NIPER Mohali. He highlighted the various achievements in the field of R&D and pharma education by the Institute. He also made a presentation for NIPER Raibareli where he holds the charge of Director. Director, NIPER Guwahati, and Director, NIPER Hajipur also made presentation for their Institutes.

Read also: NIPER, Hindustan Antibiotic sign MoU for developing 3D antimicrobial face-shields

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News